The store will not work correctly when cookies are disabled.
2-(3-(4-chlorophenyl)-5-methyl-1-phenyl-1H-pyrazol-4-yl)-5-phenyl-1,3,4-oxadiazole
ID: ALA3099511
PubChem CID: 72947070
Max Phase: Preclinical
Molecular Formula: C24H17ClN4O
Molecular Weight: 412.88
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1c(-c2nnc(-c3ccccc3)o2)c(-c2ccc(Cl)cc2)nn1-c1ccccc1
Standard InChI: InChI=1S/C24H17ClN4O/c1-16-21(24-27-26-23(30-24)18-8-4-2-5-9-18)22(17-12-14-19(25)15-13-17)28-29(16)20-10-6-3-7-11-20/h2-15H,1H3
Standard InChI Key: CNHXMARDKAFPKZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
3.7513 -11.0857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9341 -11.0815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6776 -11.8575 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3363 -12.3412 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9998 -11.8642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3315 -13.1554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6201 -13.5598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6157 -14.3763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3219 -14.7892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0340 -14.3798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0349 -13.5647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7757 -12.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4593 -10.4200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7971 -9.6747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3209 -9.0116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5068 -9.0925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1713 -9.8423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6496 -10.5023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2344 -10.4298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0516 -10.4339 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3081 -9.6580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6494 -9.1743 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9859 -9.6513 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0868 -9.4101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6912 -9.9617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4691 -9.7137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6436 -8.9145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0343 -8.3637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2587 -8.6146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0290 -8.4296 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
4 6 1 0
5 12 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
2 13 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 2 0
1 19 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
21 24 1 0
16 30 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 412.88 | Molecular Weight (Monoisotopic): 412.1091 | AlogP: 6.22 | #Rotatable Bonds: 4 |
Polar Surface Area: 56.74 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 1.31 | CX LogP: 5.93 | CX LogD: 5.93 |
Aromatic Rings: 5 | Heavy Atoms: 30 | QED Weighted: 0.35 | Np Likeness Score: -1.37 |
References
1. Ningaiah S, Bhadraiah UK, Doddaramappa SD, Keshavamurthy S, Javarasetty C.. (2014) Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation., 24 (1): [PMID:24316123] [10.1016/j.bmcl.2013.11.029] |